French drug delivery company Flamel Technologies suffered another
blow yesterday when it was revealed that TAP Pharmaceutical
Products has pulled out of deal to develop a formulation of its
big-selling gastrointestinal drug lansoprazole...
Following hot on the heels of the GSK's expansion of its vaccine
division, Novartis is seeking to take control of vaccine maker
Chiron by buying the remaining shares it does not already own in
the US firm for $4.5bn (£2.5bn).
The cost-effective benefits and research standards set to become
international has added to the attraction of outsourcing R&D to
India and China - two developing nations that are set to ease the
ever-increasing cost pressures,...
Affiliated Computer Services (ACS), announced today that it has
been awarded an additional information technology (IT) outsourcing
contract with GlaxoSmithKline (GSK), valued at $100.5 million (€82
million) over five years.
Charles River Laboratories saw a double digit boost in fiscal
second quarter revenues with a leap in operating earnings, helped
by its acquisition of Inveresk Research Group, and also to
continuing strong demand for research models...
Labcyte has announced that it has closed its latest round of
financing in which $21 milllion was raised. The funds will be used
to expand its low-volume liquid handling business with a view to
marketing the next Labcyte product in...
Pfizer has revealed that it is set to outsource some of its
technology jobs to India, harnessing the country's IT
infrastructure to focus more on clinical trial and other
R&D-related information management.
Clinical Data is to acquire Genaissance Pharmaceuticals in a deal
worth $56 million (€46.3 million). The merger allows Clinical Data
to add pharmacogenomic diagnostics and tools to its burgeoning
portfolio as it prepares to enter...